This document provides the program details for a symposium on thrombosis taking place on October 13-14, 2011 in Kuala Lumpur, Malaysia. The symposium will include presentations on topics such as the management of thrombosis, thrombophilia testing, new oral anticoagulants, antiphospholipid antibody syndrome in pregnancy, and hemostatic markers. There will also be a workshop on October 14th hosted by Stago focusing on quality control, the Stago product line, and troubleshooting for their coagulation analyzers. The event is bringing together hematologists and lab specialists from Malaysia and Australia to discuss advances in thrombosis research and management.
TIC Magazine est le premier magazine marocain francophone dédié aux Technologies de l’Information et la communication, destiné aux professionnels du secteur au Maroc
Plus d'infos sur http://www.ticmagazine.net
Formation Facebook
- Pourquoi Facebook ?
- Utiliser Facebook dans sa stratégie digitale
- Les outils
- Facebook for Business et la gestion des publicités
THIS MY DETAILED REPORT ON RAMESH HOSPIAL. IN THE SUMMER INTERNSHIP TIME. IN THIS REPORT WHAT ARE AVAILABLE IN HOPITAL AND MY WORK . MY WORK WAS CUSTOMER SATISFACTION ABOUT THE RAMESH HOSPITAL.
TIC Magazine est le premier magazine marocain francophone dédié aux Technologies de l’Information et la communication, destiné aux professionnels du secteur au Maroc
Plus d'infos sur http://www.ticmagazine.net
Formation Facebook
- Pourquoi Facebook ?
- Utiliser Facebook dans sa stratégie digitale
- Les outils
- Facebook for Business et la gestion des publicités
THIS MY DETAILED REPORT ON RAMESH HOSPIAL. IN THE SUMMER INTERNSHIP TIME. IN THIS REPORT WHAT ARE AVAILABLE IN HOPITAL AND MY WORK . MY WORK WAS CUSTOMER SATISFACTION ABOUT THE RAMESH HOSPITAL.
Understanding your heart health with your heloAlan Teh
To fully use your HELO you need to understand basic heart function, physiology and even some basic ECG knowlege. This presentation should help all HELO users.
The Malaysian Oncological Society and the European Society for Medical Oncology will be holding a joint conference to share the highlights of the ESMO 2014 Congress with South-East Asian delegates.
The conference will be held in Penang, Malaysia from 23-25 January 2015 and the theme is "Precision Medicine in Cancer Care".
Official website: http://esmomos2015penang.com.my/
For Malaysian doctors: The Medico-Legal Society of Malaysia (MLSM) and the Kuala Lumpur Regional Centre for Arbitration (KLRCA) would like to invite you for a dialogue with Datuk Seri Gopal Sri Ram on the topic "Has the Law Forced Doctors to Practice Defensive Medicine?"
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. 13 OCTOBER 2011, THURSDAY
Symposium on Recent Advances in Thrombosis
PROGRAM
0800 – 0845 Registration
0845 – 0900 Welcome Address
Dato’ Dr Chang Kian Meng, Head of Haematology Department and Senior Consultant
Haematologist, Ampang Hospital, Malaysia
Chairperson: Dr Hjh Norhanim Asidin, Head of Transfusion Unit and Blood Bank, Tengku
Ampuan Rahimah Hospital, Klang, Malaysia
0900 – 0940 Management of Thrombosis and the Role of Inferior Vena Cava Filter
Dr Jay Suriar Rajasuriar, Clinical Specialist in Hematology, Ampang Hospital, Malaysia
0940 – 1020 Thrombophilia Testing in Clinical Setting
Dato’ Dr Chang Kian Meng, Head of Haematology Department and Senior Consultant
Haematologist, Ampang Hospital, Malaysia
1020 – 1050 Tea Break
1050 – 1130 Duration of Anticoagulation & the Role of D-Dimers
Dr Jameela Sathar, Senior Consultant Haematologist, Ampang Hospital, Malaysia
1130 – 1210 New Oral Anticoagulants
Dr Haris Abdul Rahman, Senior Lecturer and Consultant Haematologist, University
Malaya Medical Center, Malaysia
1210 – 1250 Lupus Anticoagulant Testing
Mrs Elizabeth Mary Duncan, Scientist-In-Charge and Group Leader, Institute of Medical and
Veterinary Science, Adelaide, Australia
1250 – 1400 Lunch
Chairperson: Dr Jameela Sathar, Senior Consultant Haematologist, Ampang Hospital, Malaysia
1400 – 1440 Antiphospholipid Antibody Syndrome in pregnancy
Dr Jerome Tan Tsen Chuen, Clinical Specialist in Hematology, Ampang Hospital, Malaysia
1440 – 1520 Mechanical heart valve and pregnancy
To be confirmed
1520 – 1600 Anti-Xa monitoring
Mrs Elizabeth Mary Duncan, Scientist-In-Charge and Group Leader, Institute of Medical and
Veterinary Science, Adelaide, Australia
1600 - 1640 Haemostatic Markers and Prothrombin Genes in Arterial Thrombosis
Assoc. Prof. Dr Wan Zaidah Bt Abdullah, Haematologist, University Sains Malaysia Hospital,
Kubang Kerian, Malaysia
1640 Tea Break and End
3. 14 OCTOBER 2011, FRIDAY
Stago User Group Workshop
0800 – 0830 Registration
0830– 0840 Welcome
Mr Heng Chin Lee, General Sales Manager, All Eights, Malaysia
0840 – 0920 Quality Control in Haemostasis and Laboratory Accreditation
Dr Azizon Othman, Head of Pathology Department, Tuanku Jaafar Hospital, Seremban,
Malaysia
0920 – 0940 Qualiris: A New Alternative of External Quality Assurance
Ms Axelle Verrier, Product Manager, Diagnostica Stago, France
0940 – 1000 Stago in Malaysia (and Singapore)
Mr Chong Si Zhe, Product Manager, All Eights, Malaysia
1000 – 1020 Tea Break
1020 – 1100 Shortened APTT, Repeat or Release?
Assoc. Prof. Dr Wan Zaidah Bt Abdullah, Haematologist, University Sains Malaysia Hospital,
Kubang Kerian, Malaysia
1100 – 1130 User Experience in STA-R Evolution
Dr Siti Zaharah Bt Idris, Pathologist, Sultanah Bahiyah Hospital, Alor Setar, Malaysia
1130 – 1200 Troubleshooting and Quality Control
Application Specialist, All Eights, Malaysia
1200 Lunch & End of the program
4. Chairpersons and Speakers
Dato’ Dr Chang Kian Meng Dr Hjh Norhanim Bt Asidin
Head of Hematology Department and Head of Transfusion Unit and Blood Bank
Senior Consultant Haematologist Hospital Tengku Ampuan Rahimah, Klang
Hospital Ampang Malaysia
Malaysia
Dr Azizon Othman
Dr Jameela Sathar Head of Pathology Department
Senior Consultant Haematologist Hospital Tuanku Jaafar, Seremban
Hospital Ampang Malaysia
Malaysia
Dr Siti Zaharah Bt Idris
Mrs Elizabeth Mary Duncan Pathologist
Scientist-in-charge and group leader of the Hospital Sultanah Bahiyah, Alor Setar
Haemostasis Section, Division of Haematology, Malaysia
Institute of Medical and Veterinary Science,
Adelaide, Australia.
Dr Haris Abdul Rahman
Dr Jay Suriar Rajasuriar Senior Lecturer and Consultant Haematologist
Clinical Specialist in Haematology University Malaya Medical Center
Hospital Ampang Malaysia
Malaysia
Dr Jerome Tan Tsen Chuen Ms Axelle Verrier
Clinical Specialist in Haematology Product Manager
Hospital Ampang Diagnostica Stago, France
Malaysia